Pancreatic cancer treatment: better, but a long way to go.


Journal

Surgery today
ISSN: 1436-2813
Titre abrégé: Surg Today
Pays: Japan
ID NLM: 9204360

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 25 03 2020
accepted: 10 04 2020
pubmed: 1 6 2020
medline: 24 10 2020
entrez: 1 6 2020
Statut: ppublish

Résumé

Remarkable progress has been made in treating pancreatic cancer over the past century, including refinement of our surgical techniques and improvements in adjuvant and neoadjuvant therapies. Despite these advances, the incidence of pancreatic cancer is rising globally, and it remains a deadly disease. In this review, we highlight the historical perspectives of pancreatic cancer treatment and outline the areas of future advancement that will assist progression towards better outcomes. Areas of future advancement include improving prevention strategies and early detection, refining our molecular understanding of pancreatic cancer, identifying more effective systemic therapies, and improving quality of life and surgical outcomes. Furthermore, systems need to be put in place to ensure all patients with pancreatic cancer receive high quality care and are given the appropriate options and sequence of therapy. This is best achieved through multidisciplinary care.

Identifiants

pubmed: 32474642
doi: 10.1007/s00595-020-02028-0
pii: 10.1007/s00595-020-02028-0
pmc: PMC7837389
mid: NIHMS1599537
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1117-1125

Subventions

Organisme : NCATS NIH HHS
ID : TL1 TR002533
Pays : United States

Références

Cancer Res. 2019 Jan 15;79(2):372-386
pubmed: 30401713
Gut. 2018 May;67(5):789-804
pubmed: 29574408
Br J Surg. 2014 Apr;101(5):523-9
pubmed: 24615349
Ann Surg. 2018 Jul;268(1):151-157
pubmed: 28486387
Nat Genet. 2015 Oct;47(10):1168-78
pubmed: 26343385
Rev Surg. 1963 Jul-Aug;20:221-5
pubmed: 14000261
Science. 2019 Jun 21;364(6446):1156-1162
pubmed: 31221853
Ann Surg. 1935 Oct;102(4):763-79
pubmed: 17856666
J Immunother. 2010 Oct;33(8):828-33
pubmed: 20842054
Gastroenterology. 1987 Jan;92(1):60-7
pubmed: 3465666
J Am Coll Surg. 2018 Jul;227(1):55-62
pubmed: 29605725
Ann Surg. 2013 Oct;258(4):554-9; discussion 559-62
pubmed: 24002300
Surg Clin North Am. 2018 Feb;98(1):25-35
pubmed: 29191275
Thromb Res. 1994 May 15;74(4):335-46
pubmed: 8085235
Surgery. 1999 Mar;125(3):250-6
pubmed: 10076608
JAMA. 2013 Oct 9;310(14):1473-81
pubmed: 24104372
Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):207-220
pubmed: 30718832
Pancreatology. 2017 Sep - Oct;17(5):738-753
pubmed: 28735806
Sci Transl Med. 2017 Jul 12;9(398):
pubmed: 28701476
N Engl J Med. 2012 Jun 28;366(26):2455-65
pubmed: 22658128
Ann Surg. 2019 Jan;269(1):2-9
pubmed: 30080726
Arch Surg. 1985 Aug;120(8):899-903
pubmed: 4015380
J Clin Oncol. 2016 Jun 10;34(17):2010-9
pubmed: 27114589
Nat Rev Gastroenterol Hepatol. 2009 Dec;6(12):699-708
pubmed: 19806144
JAMA. 2010 Sep 8;304(10):1073-81
pubmed: 20823433
Surg Gynecol Obstet. 1946 Jun;82:623-31
pubmed: 20983134
Jpn J Clin Oncol. 2019 Feb 1;49(2):190-194
pubmed: 30608598
Future Oncol. 2018 Jan;14(1):13-22
pubmed: 29235360
Lancet. 2017 Mar 11;389(10073):1011-1024
pubmed: 28129987
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Cancer. 1968 Nov;22(5):939-44
pubmed: 4301104
J Clin Oncol. 2020 Jun 1;38(16):1763-1773
pubmed: 32105518
Nature. 2016 Mar 3;531(7592):47-52
pubmed: 26909576
Adv Surg. 2010;44:293-311
pubmed: 20919528
N Engl J Med. 2004 Mar 18;350(12):1200-10
pubmed: 15028824
Carcinogenesis. 2016 May;37(5):481-90
pubmed: 26905587
Ann Surg. 1999 Dec;230(6):776-82; discussion 782-4
pubmed: 10615932
Ann Surg. 1987 Sep;206(3):358-65
pubmed: 3632096
Ann Surg. 1964 Jun;159:945-58
pubmed: 14170295
Clin Cancer Res. 2018 Mar 15;24(6):1344-1354
pubmed: 29288237
Surg Endosc. 2015 Jul;29(7):1871-8
pubmed: 25294551
Lancet Gastroenterol Hepatol. 2019 Mar;4(3):199-207
pubmed: 30685489
J Gastrointest Oncol. 2012 Jun;3(2):105-19
pubmed: 22811878
Am J Surg Pathol. 2015 Dec;39(12):1730-41
pubmed: 26559377
Ann Surg. 2019 Dec;270(6):1147-1155
pubmed: 29771723
Nat Med. 2011 Apr;17(4):500-3
pubmed: 21460848
Br J Cancer. 2018 Jan;118(2):e3
pubmed: 29361630
Ann Surg. 2016 Apr;263(4):664-72
pubmed: 26636243
Gut. 2020 Jan;69(1):7-17
pubmed: 31672839
Lancet. 2016 Jul 16;388(10041):248-57
pubmed: 27265347
N Engl J Med. 2018 Dec 20;379(25):2395-2406
pubmed: 30575490
J Clin Oncol. 2019 Aug 10;37(23):2082-2088
pubmed: 31180816
Ann Surg. 2020 Jan;271(1):1-14
pubmed: 31567509
Lancet Gastroenterol Hepatol. 2019 Dec;4(12):934-947
pubmed: 31648972
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
JAMA Oncol. 2019 Oct 01;5(10):1431-1438
pubmed: 31318392
Arch Surg. 2009 Dec;144(12):1179-84
pubmed: 20026839
Gastroenterology. 2018 Sep;155(3):740-751.e2
pubmed: 29803839
J Clin Oncol. 2020 Jun 1;38(16):1757-1759
pubmed: 32119598
Science. 2008 Sep 26;321(5897):1801-6
pubmed: 18772397
Chin J Cancer Res. 2015 Aug;27(4):332-48
pubmed: 26361403
Ann Gastroenterol Surg. 2018 Jun 22;2(4):274-281
pubmed: 30003190

Auteurs

Robert J Torphy (RJ)

Department of Surgery, School of Medicine, Cancer Center, University of Colorado, Anschutz Medical Campus, 12631 E. 17th Avenue, C-305, Aurora, CO, 80045, USA.

Yuki Fujiwara (Y)

Department of Surgery, School of Medicine, Cancer Center, University of Colorado, Anschutz Medical Campus, 12631 E. 17th Avenue, C-305, Aurora, CO, 80045, USA.

Richard D Schulick (RD)

Department of Surgery, School of Medicine, Cancer Center, University of Colorado, Anschutz Medical Campus, 12631 E. 17th Avenue, C-305, Aurora, CO, 80045, USA. richard.schulick@cuanschutz.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH